Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Nature Reviews. Genetics|November 6, 2025
Genomics of drug target prioritization for complex diseasesRobert Chen, Áine Duffy, Ron DoVascular|June 25, 2021
A prospective randomized feasibility trial comparing angiography and angiography with intravascular ultrasound for treatment of hemodialysis access failuresWilliam Shutze, Rachel Rendon, Victoria Lee, et al.Genome Biology|March 11, 2025
Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver diseaseRobert Chen, Ben Omega Petrazzini, Áine Duffy, et al.Genome Medicine|June 12, 2026
Genetically supported drug target prioritization for rare diseasesRobert Chen, Áine Duffy, Matthew Mort, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Incidence of Mortality and Complications in High-Risk Pulmonary Embolism: A Systematic Review and Meta-AnalysisMitchell J Silver, Jay Giri, Áine Duffy, et al.Science Advances|September 12, 2020
Tissue-specific genetic features inform prediction of drug side effects in clinical trialsÁine Duffy, Marie Verbanck, Amanda Dobbyn, et al.Communications Biology|August 20, 2022
A tissue-level phenome-wide network map of colocalized genes and phenotypes in the UK BiobankGhislain Rocheleau, Iain S Forrest, Áine Duffy, et al.Cell Reports Methods|July 27, 2025
Genetic analyses of eight complex diseases using predicted continuous representations of diseaseRobert Chen, Ghislain Rocheleau, Ben Omega Petrazzini, et al.Cell Reports. Medicine|April 20, 2024
Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare systemIain S Forrest, Áine Duffy, Joshua K Park, et al.Atherosclerosis|January 12, 2025
Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK BiobankKyle Gibson, Iain S Forrest, Ben O Petrazzini, et al.Pageof 3